Patients were instructed to address

Patients were instructed to address questions concerning the medical treatment to physician throughout the study, and the ability of the patients to tolerate the treatment was satisfactory. The response to combined treatment with topiramate and acetazolamide was good in most patients with ICH, and 69 (74%) out 93 patients achieved ≥50% reduction in headache days.

結果 (繁體中文) 1:

指導患者有關醫療醫師在研究地址的問題，患者耐受治療的能力是令人滿意的。與托吡酯和乙酰唑胺聯合治療的反應是在大多數患者中與ICH良好，和69（74％）93出來例，取得在頭痛天減少≥50％。

結果 (繁體中文) 2:

โรคพิษร้ายเป็นอันตรายในมนุษย์. (n = 147)

結果 (繁體中文) 3:

在整個研究過程中，指導患者向醫生提出與醫療相關的問題，患者對治療的耐受能力令人滿意。托吡酯和乙醯唑胺聯合治療多數腦出血患者療效良好，93例患者中69例（74%）頭痛天數减少≥50%。